INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
01Overview02Follow the Money03Daily Brief04Live05Congress06Directory07Corporate Insiders08Government Money09Political Influence10Institutions11Washington Network12Follow the Power13Disclosure Clock14AI Investigator15Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 415m ago
HOUSE PTR15m ago
SEC 13F15m ago
ROBINHOOD CHAIN14m ago
SEC FORM 4/Open-market saleVerified data

Lee Kevin sold BCYC

Director, CHIEF EXECUTIVE OFFICER · BICYCLE THERAPEUTICS PLC · Ordinary Shares

Side
SELL
Value
$21K
Shares
6,167
Price
$3.47
Executed
Oct 2, 2026
Disclosed
Oct 6, 2026
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Oct 2 executedOct 6, 2026 disclosed

BCYC · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
32/ 100 · ELEVATED
Methodology →
  • Transaction type+12 / 20

    Open-market sale

  • Relative size+1 / 25

    $21K reported value · 1.0% of prior position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+4 / 15

    4 prior trades recorded in this security

  • Frequency & clustering+15 / 15

    5 other actors traded the same direction within 14 days

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · BCYC

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    13
    PS
    Perry Jennifer ScottChief Operating Officer
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale · 10b5-1 plan
    		SELL$3,796
    1,094 sh
    		Oct 2, 2026Oct 6, 2026
    traded Oct 2, 2026
    		+4dSEC FORM 4

    Evidence

    32
    LK
    Lee KevinDirector, CHIEF EXECUTIVE OFFICER
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale
    		SELL$5,848
    1,638 sh
    		Oct 5, 2026Oct 6, 2026
    traded Oct 5, 2026
    		+1dSEC FORM 4

    Evidence

    29
    TA
    Thompson Travis AlvinChief Financial Officer
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale
    		SELL$3,099
    893 sh
    		Oct 2, 2026Oct 6, 2026
    traded Oct 2, 2026
    		+4dSEC FORM 4

    Evidence

    29
    HF
    Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFF
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale
    		SELL$864
    242 sh
    		Oct 5, 2026Oct 6, 2026
    traded Oct 5, 2026
    		+1dSEC FORM 4

    Evidence

    32
    SM
    Skynner MichaelCHIEF SCIENTIFIC OFFICER
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale
    		SELL$6,739
    1,942 sh
    		Oct 2, 2026Oct 6, 2026
    traded Oct 2, 2026
    		+4dSEC FORM 4

    Evidence

    32
    SM
    Skynner MichaelCHIEF SCIENTIFIC OFFICER
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale
    		SELL$1,796
    503 sh
    		Oct 5, 2026Oct 6, 2026
    traded Oct 5, 2026
    		+1dSEC FORM 4

    Evidence

    29
    TA
    Thompson Travis AlvinChief Financial Officer
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale
    		SELL$282
    79 sh
    		Oct 5, 2026Oct 6, 2026
    traded Oct 5, 2026
    		+1dSEC FORM 4

    Evidence

    29
    HF
    Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFF
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale
    		SELL$5,455
    1,572 sh
    		Oct 2, 2026Oct 6, 2026
    traded Oct 2, 2026
    		+4dSEC FORM 4

    Evidence

    40
    SC
    Swanton Robert CharlesDirector
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale
    		SELL$12K
    3,431 sh
    		Oct 2, 2026Oct 6, 2026
    traded Oct 2, 2026
    		+4dSEC FORM 4

    Evidence

    13
    PS
    Perry Jennifer ScottChief Operating Officer
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale · 10b5-1 plan
    		SELL$1,232
    326 sh
    		Oct 5, 2026Oct 6, 2026
    traded Oct 5, 2026
    		+1dSEC FORM 4

    Evidence

    13
    PS
    Perry Jennifer ScottChief Operating Officer
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale · 10b5-1 plan
    		SELL$285
    80 sh
    		Oct 5, 2026Oct 6, 2026
    traded Oct 5, 2026
    		+1dSEC FORM 4

    Evidence

    22
    PS
    Perry Jennifer ScottChief Operating Officer
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale · 10b5-1 plan
    		SELL$4,424
    1,036 sh
    		Jul 2, 2026Jul 7, 2026
    traded Jul 2, 2026
    		+5dSEC FORM 4

    Evidence

    16
    PS
    Perry Jennifer ScottChief Operating Officer
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale · 10b5-1 plan
    		SELL$185
    43 sh
    		Jul 6, 2026Jul 7, 2026
    traded Jul 6, 2026
    		+1dSEC FORM 4

    Evidence

    38
    HF
    Hannay Michael Charles FergusonCHIEF PROD & SUPPLY CHAIN OFF
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale
    		SELL$6,431
    1,506 sh
    		Jul 2, 2026Jul 7, 2026
    traded Jul 2, 2026
    		+5dSEC FORM 4

    Evidence

    38
    LK
    Lee KevinDirector, CHIEF EXECUTIVE OFFICER
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale
    		SELL$25K
    5,905 sh
    		Jul 2, 2026Jul 7, 2026
    traded Jul 2, 2026
    		+5dSEC FORM 4

    Evidence

    32
    LK
    Lee KevinDirector, CHIEF EXECUTIVE OFFICER
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale
    		SELL$7,486
    1,737 sh
    		Jul 6, 2026Jul 7, 2026
    traded Jul 6, 2026
    		+1dSEC FORM 4

    Evidence

    38
    SM
    Skynner MichaelCHIEF SCIENTIFIC OFFICER
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale
    		SELL$7,938
    1,859 sh
    		Jul 2, 2026Jul 7, 2026
    traded Jul 2, 2026
    		+5dSEC FORM 4

    Evidence

    32
    SM
    Skynner MichaelCHIEF SCIENTIFIC OFFICER
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale
    		SELL$2,293
    532 sh
    		Jul 6, 2026Jul 7, 2026
    traded Jul 6, 2026
    		+1dSEC FORM 4

    Evidence

    32
    TA
    Thompson Travis AlvinChief Financial Officer
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale
    		SELL$448
    104 sh
    		Jul 6, 2026Jul 7, 2026
    traded Jul 6, 2026
    		+1dSEC FORM 4

    Evidence

    16
    PS
    Perry Jennifer ScottChief Operating Officer
    BCYCBICYCLE THERAPEUTICS PLC
    Open-market sale · 10b5-1 plan
    		SELL$1,445
    333 sh
    		Jul 6, 2026Jul 7, 2026
    traded Jul 6, 2026
    		+1dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001776938-26-000008
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Oct 2, 2026
    Published
    Oct 6, 2026
    Ingested by INSIDER
    Nov 5, 02:13 UTC
    Last re-read
    Nov 5, 02:13 UTC

    Extracted facts

    Filer
    Lee Kevin
    Role
    Director, CHIEF EXECUTIVE OFFICER
    Transaction
    Open-market saleAs filed: “S”
    Asset
    BICYCLE THERAPEUTICS PLC
    Ticker
    BCYC
    Shares
    6,167
    Price per share
    $3.47
    Value
    $21,399
    Execution date (reported)
    Oct 2, 2026
    Owned after transaction
    597.5K shares
    Days from execution to publication
    4

    Calculation

    Value = shares × reported price per share

    • Shares: 6,167
    • Price: $3.47

    = $21,399

    What this establishes

    Lee Kevin filed this Form 4 reporting a open-market sale of BCYC on Oct 2, 2026. It became public on Oct 6, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Director, CHIEF EXECUTIVE OFFICER
    Lee Kevincik:0001776938
    Issuer
    BICYCLE THERAPEUTICS PLCcik:0001761612

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.